Chief Legal Officer & General Counsel · USANA HEALTH SCIENCES INC (USNA)

Joshua Foukas

A named executive officer of USANA HEALTH SCIENCES in every fiscal year CompBrief holds from FY2021 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$1,268,334

Salary $487,630Stock awards $731,477

FY2023: $1,292,741

5th of 5 named executive officers at Usana Health Sciences by FY2024 total.

5 named officers on file for USANA HEALTH SCIENCES, FY2024

Joshua Foukas’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing
  • USNA’s disclosed peer group of 15 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how USANA HEALTH SCIENCES’s whole pay program stands against its peers

  • USANA HEALTH SCIENCES’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on USNA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 4, 2025 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Joshua Foukas’s full pay file as a PDF — free

More than this page: up to 10 years of Joshua’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Joshua Foukas compensation by year

USANA HEALTH SCIENCES Summary Compensation Table · all 4 fiscal years held
In US dollars, as USANA HEALTH SCIENCES reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022FY2023FY2024
Salary$471,836$485,991$487,630$487,630
Bonus$0$0$0$0
Stock awards$568,132$585,164$731,465$731,477
Option awards$0$0$0$0
Non-equity incentive$205,673$73,167$60,661$35,938
Pension and deferred compensation$0$0$0$0
All other$10,150$10,675$12,985$13,289
Total$1,255,791$1,154,997$1,292,741$1,268,334

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: USANA HEALTH SCIENCES INC DEF 14A filed April 4, 2025, accession 0000896264-25-000105, and prior-year filings. Open the filing on EDGAR.

How this page was built: the USANA HEALTH SCIENCES INC filed document, accession 0000896264-25-000105. Every figure is read from that document and cited to the page and table it appears in. Filed April 4, 2025.

$1.3M
$1.2M
$1.3M
$1.3M
FY21
FY22
FY23
FY24
SalaryNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU26,306$511,389—
RSU10,789$209,738—
RSU6,221$120,936—
RSU1,571$30,540—
PSU6,088——

Per the Outstanding Equity Awards at Fiscal Year-End table in USANA HEALTH SCIENCES INC's FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

15 Form 4 lines since the FY2024 proxy (filed April 4, 2025)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-05-07Sale—3,791$19.820
2026-02-27Exercise or conversion derivative—6,577$0.0066,693
2026-02-27Exercise or conversion—6,577—6,577
2026-02-27Tax withholding—2,786$21.523,791
2026-02-20Sale—4,461$21.340
2026-02-19Grant or award derivative—36,662$0.0073,270
2026-02-08Exercise or conversion derivative—3,597$0.0036,608
2026-02-08Exercise or conversion—3,597—6,047

The 8 most recent of 15 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

USANA HEALTH SCIENCES’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Jim BrownChief Executive Officer & President$3,362,107
G. Douglas HekkingChief Financial Officer$1,440,953
Walter NootChief Operating Officer$1,438,431
Brent NeidigChief Commercial Officer$1,299,581
Joshua Foukas · this pageChief Legal Officer & General Counsel$1,268,334

The full USANA HEALTH SCIENCES compensation record

free company brief

This page is one person within USANA HEALTH SCIENCES's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the USANA HEALTH SCIENCES proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are USANA HEALTH SCIENCES's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Joshua Foukas's compensation dossier · One-time report. No refunds.